Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 257 for “"Targeted Therapeutics"”.

  1. Phosphonium-functionalised gold nanoparticles for mitochondria targeted therapeutics.

    The work presented in this thesis demonstrates that triarylphosphoniopropyl-thiosulfate zwitterions and w-thioacetylpropyl(triphenyl)phosphonium salts can be used to prepare cationic, water-soluble gold nanoparticles with mean core sizes in the range of 2.5-5 nm. Phosphonium-functionalised gold …

    sheffield-hallam Download PDF for Phosphonium-functionalised gold nanoparticles for mitochondria targeted therapeutics. (opens in a new tab)

  2. Targeted therapeutics for non small cell lung carcinoma

    … (GelNP) that will act as a vehicle to deliver targeted siRNAs against NSCLC cells in combination with Cisplatin. The cetuximab (Ab), an EGFR targeting antibody, shall be attached to the surface. The AXL and FN14 SiRNAs shall be conjugated to the antibody by the thio-ether linkage. The cetuximab …

    missouri Repository record for Targeted therapeutics for non small cell lung carcinoma (opens in a new tab)

  3. Biointormatics of Targeted Therapeutics And Applications in Drug Discovery

    … certain targets may exert therapeutic value and therapeutics directed at those targets are then developed. In this big data era, development of databases and methods to store, retrieve, organize and analyze the ever-increasing targeted therapeutics data are of importance to drug discovery. This …

    nus Repository record for Biointormatics of Targeted Therapeutics And Applications in Drug Discovery (opens in a new tab) Download file for Biointormatics of Targeted Therapeutics And Applications in Drug Discovery (opens in a new tab)

  4. Development of monoclonal antibody targeted therapeutics for prostate cancer

    Prostate cancer is the second most frequently diagnosed cancer among men globally, claiming the lives of over 370,000 individuals each year. This high mortality rate reflects the limitations of current prostate cancer treatment strategies. Current approaches to prostate cancer treatment are …

    adelaide Repository record for Development of monoclonal antibody targeted therapeutics for prostate cancer (opens in a new tab)

  5. Developing microbiome-targeted therapeutics through community-based metabolic modelling

    The gastrointestinal microbiome plays a crucial role in host health, influencing nutrient absorption, immune function, and resistance to pathogens. In poultry, a healthy gut microbiome is essential for optimal growth performance and disease resistance. The ban on antibiotic growth promoters has …

    toronto-retro Repository record for Developing microbiome-targeted therapeutics through community-based metabolic modelling (opens in a new tab)

  6. Arsonium and phosphonium-functionalized gold nanoparticles for mitochondria targeted therapeutics

    This thesis presents a body of original research describing the synthesis, characterisation and biological properties of novel arsonium- and phosphonium- alkylthiosulfate zwitterions and thioacetate salts and gold nanoparticles functionalized with triphenylarsoniumpropylthiolate ligands. Chapter 1 …

    sheffield-hallam Repository record for Arsonium and phosphonium-functionalized gold nanoparticles for mitochondria targeted therapeutics (opens in a new tab) Download PDF for Arsonium and phosphonium-functionalized gold nanoparticles for mitochondria targeted therapeutics (opens in a new tab)

  7. Development of carbohydrate-based materials as targeted therapeutics and biomimetics

    … structures for the development of improved therapeutics. To this end, polyamidosaccharides (PASs), which contain α-1,2 amide linkages replacing native glycosidic bonds between the repeating sugar units, are accessed via an anionic ring-opening polymerization of a fused bicyclic β-lactam …

    bu Repository record for Development of carbohydrate-based materials as targeted therapeutics and biomimetics (opens in a new tab)

  8. A self-assembling coiled-coil peptide platform for antibody-targeted therapeutics

    … diverse payloads to create safe next-generation therapeutics. We first developed a supramolecular assembly conjugation method based on coiled-coil peptides to generate a robust site-specific ADC. This approach affords modular conjugation of multiple payloads. An ADC created via this platform …

    bu Repository record for A self-assembling coiled-coil peptide platform for antibody-targeted therapeutics (opens in a new tab)

  9. De novo designed protein switches to enable increased specificity of targeted therapeutics

    Targeted immunotherapies typically rely on the recognition of a single cell-surface marker, and as such, their specificity is limited and prone to incidentally harming healthy cells. This is problematic for developing treatments for solid tumors where ‘tumor-specific’ antigens are also expressed on …

    washington Repository record for De novo designed protein switches to enable increased specificity of targeted therapeutics (opens in a new tab)

  10. Delivery and efficacy of targeted therapeutics and imaging agents for brain tumors

    … Despite advances in developing molecularly-targeted anti-cancer therapeutics in treating peripheral tumors, there is no effective therapeutic for brain tumors that demonstrated dramatic improvement in patient survival. One of the major reasons of having lack of efficacy in central nervous …

    umn Repository record for Delivery and efficacy of targeted therapeutics and imaging agents for brain tumors (opens in a new tab)

  11. Computationally driven design of small-molecule reversible covalent inhibitors for targeted therapeutics

    Reversible covalent inhibitors (RCIs) represent a promising strategy for achieving durable and selective target engagement in oncological therapy. By forming transient yet sufficiently stable covalent adducts, RCIs sustain target engagement while avoiding the cumulative toxicity associated with …

    laurentian Repository record for Computationally driven design of small-molecule reversible covalent inhibitors for targeted therapeutics (opens in a new tab)

  12. Development of chemical tools for biomarker detection and targeted therapeutics for precision medicine

    Submission published under a 24 month embargo labeled 'Closed Access', the embargo will last until 2025-12-01

    uiuc Repository record for Development of chemical tools for biomarker detection and targeted therapeutics for precision medicine (opens in a new tab)

  13. High-throughput screen reveals novel resistance mechanisms of Bruton’s Tyrosine Kinase to targeted therapeutics

    … inhibitors (TKIs) are a burgeoning class of therapeutics that has revolutionized the treatment of leukemias and lymphomas. These small molecules potently antagonize the tyrosine kinases involved in malignant signal transduction pathways while leaving innocuous pathways intact. While these …

    texas Repository record for High-throughput screen reveals novel resistance mechanisms of Bruton’s Tyrosine Kinase to targeted therapeutics (opens in a new tab)

  14. Redefining the Management of Perianal Fistulising Crohn’s Disease: From Streamlined Care to Targeted Therapeutics

    … necrosis factor (anti-TNF) agents and newer targeted therapies, rates of sustained fistula healing remain modest. Furthermore, existing clinical classification systems are largely anatomy-based and may not adequately reflect the underlying biological heterogeneity of pfCD. Accordingly, this …

    unsw Repository record for Redefining the Management of Perianal Fistulising Crohn’s Disease: From Streamlined Care to Targeted Therapeutics (opens in a new tab)

  15. PROGRAMMABLE M13 HYPERPHAGE DISPLAY OF DIVERSE ANIMAL TOXIN LIBRARIES TO DISCOVER MEMBRANE PROTEIN TARGETED THERAPEUTICS

    … of these binders as scaffolds for novel therapeutics. Altogether, our platform offers a promising approach for membrane protein-targeted drug discovery and exploring the structural diversity of cysteine-rich miniproteins.

    jhu Repository record for PROGRAMMABLE M13 HYPERPHAGE DISPLAY OF DIVERSE ANIMAL TOXIN LIBRARIES TO DISCOVER MEMBRANE PROTEIN TARGETED THERAPEUTICS (opens in a new tab) Embargoed until 2027-08-01

  16. Repurposing Mitochondria-Targeted Therapeutics To Ameliorate Vascular and Tubular Complications of Kidney Injury and Disease

    … development and/or repurposing of mitochondria-targeted therapeutics for the potential treatment of kidney diseases has recently surged. Although novel therapeutics and promising new drug targets have been identified, drug repurposing for kidney diseases offers numerous advantages over …

    arizona-thes Repository record for Repurposing Mitochondria-Targeted Therapeutics To Ameliorate Vascular and Tubular Complications of Kidney Injury and Disease (opens in a new tab)

  17. Design of Protein-Derived Carbon Dots for Targeted Biomarker Labeling for Diagnostic Bio-Imaging and Targeted Therapeutics

    … platform for bioimaging, biosensing, and targeted therapeutics. CD parameter optimization synthesis techniques were designed using bovine serum albumin as a model protein to enable rational design of protein-derived CDs with desired properties. This enables control of CDs photoluminescence …

    ttu Repository record for Design of Protein-Derived Carbon Dots for Targeted Biomarker Labeling for Diagnostic Bio-Imaging and Targeted Therapeutics (opens in a new tab)

  18. Investigating cellular plasticity in PDAC: PI3K pathway utilization to circumvent MAPK-targeted therapeutics, and an implication for the glycan receptor Clec4f in metaplastic neuroendocrine cells.

    The most common type of pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC) is a particularly lethal disease, with a 5-year survival rate of only 8%. Poor outcomes are attributed in part to late detection and poor response to current therapeutic strategies. Therefore, understanding PDAC …

    ku Repository record for Investigating cellular plasticity in PDAC: PI3K pathway utilization to circumvent MAPK-targeted therapeutics, and an implication for the glycan receptor Clec4f in metaplastic neuroendocrine cells. (opens in a new tab)

Page 1 of 13